U.S. flag

An official website of the United States government

NM_000478.6(ALPL):c.649-1G>A AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 28, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001970877.3

Allele description

NM_000478.6(ALPL):c.649-1G>A

Gene:
ALPL:alkaline phosphatase, biomineralization associated [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.12
Genomic location:
Preferred name:
NM_000478.6(ALPL):c.649-1G>A
HGVS:
  • NC_000001.11:g.21568103G>A
  • NG_008940.1:g.63739G>A
  • NG_008940.2:g.64121G>A
  • NM_000478.6:c.649-1G>AMANE SELECT
  • NM_001127501.4:c.484-1G>A
  • NM_001177520.3:c.418-1G>A
  • NM_001369803.2:c.649-1G>A
  • NM_001369804.2:c.649-1G>A
  • NM_001369805.2:c.649-1G>A
  • NC_000001.10:g.21894596G>A
Links:
dbSNP: rs2148171286
NCBI 1000 Genomes Browser:
rs2148171286
Molecular consequence:
  • NM_000478.6:c.649-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001127501.4:c.484-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001177520.3:c.418-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001369803.2:c.649-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001369804.2:c.649-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001369805.2:c.649-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002265210Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Feb 28, 2023)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Splicing in action: assessing disease causing sequence changes.

Baralle D, Baralle M.

J Med Genet. 2005 Oct;42(10):737-48. Review.

PubMed [citation]
PMID:
16199547
PMCID:
PMC1735933

A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia.

Weiss MJ, Cole DE, Ray K, Whyte MP, Lafferty MA, Mulivor RA, Harris H.

Proc Natl Acad Sci U S A. 1988 Oct;85(20):7666-9.

PubMed [citation]
PMID:
3174660
PMCID:
PMC282253
See all PubMed Citations (6)

Details of each submission

From Invitae, SCV002265210.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change affects an acceptor splice site in intron 6 of the ALPL gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ALPL are known to be pathogenic (PMID: 3174660, 10679946, 32973344, 33814268). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ALPL-related conditions. ClinVar contains an entry for this variant (Variation ID: 1473817). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 17, 2024